dsm-firmenich halts animal grade Vitamin A and reduces Vitamin E production

Royal dsm-firmenich, a global purpose-led science-based company, today announces a halt to Rovimix® Vitamin A production in Sisseln, Switzerland, for at least 2 months commencing January 2, 2023. Rovimix® Vitamin E-50 production will be significantly impacted as well due to its common upstream infrastructure.

At the start of the month November, dsm-firmenich communicated to clients the necessity to enact price increases for its high-quality vitamins to justify continuation of production in Europe in the current challenging cost environment. With higher energy costs foreseen this winter, dsm-firmenich has decided to halt Rovimix® Vitamin A production in Sisseln, Switzerland, which also impacts Rovimix® Vitamin E-50 production.

Existing contractual commitments will be honored and allocation procedures have been activated across the global production network to enact this in an orderly manner.

dsm-firmenich is committed to sustainable production of the highest quality feed additives, including the longstanding Rovimix® product range produced in Sisseln, Switzerland, provided that aligns with our aim to generate sustainable profitable growth.